California Institute of Renal Research - La Mesa ( Site 0682) — La Mesa, California

California Institute of Renal Research - La Mesa ( Site 0682) is a clinical research site located in La Mesa, California, United States 91941.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

California Institute of Renal Research - La Mesa ( Site 0682) has participated in 1 clinical trials.

Therapeutic areas: End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in La Mesa

Browse all research sites in California · View every site in La Mesa

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for California Institute of Renal Research - La Mesa ( Site 0682)?

California Institute of Renal Research - La Mesa ( Site 0682) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has California Institute of Renal Research - La Mesa ( Site 0682) conducted?

California Institute of Renal Research - La Mesa ( Site 0682) has 1 clinical trials on record. Their work covers End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Is California Institute of Renal Research - La Mesa ( Site 0682) accredited by Crixeo Clinical Trials?

California Institute of Renal Research - La Mesa ( Site 0682) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about California Institute of Renal Research - La Mesa ( Site 0682)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.